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Nox4 Is Critical for Hypoxia-Inducible Factor 2-A Transcriptional
Activity in von Hippel-Lindau–Deficient Renal Cell Carcinoma
Jodi K. Maranchie and Ye Zhan
Departments of Surgery and Cell Biology, University of Massachusetts, Worcester, Massachusetts
Abstract
Inactivation of the von Hippel-Lindau tumor suppressor (VHL)
is an early event in >60% of sporadic clear cell renal cell
carcinoma (RCC). Loss of VHL E3 ubiquitin ligase function
results in accumulation of the A-subunit of the hypoxia-
inducible heterodimeric transcription factor (HIF-A) and
transcription of an array of genes including vascular
endothelial growth factor, transforming growth factor-A,
and erythropoietin. Studies have shown that HIF-A can be
alternatively activated by reactive oxygen species. Nox4 is an
NADP(H) oxidase that generates signaling levels of superoxide
and is found in greatest abundance in the distal renal tubules.
To determine if Nox4 contributes to HIF activity in RCC, we
examined the impact of Nox4 expression on HIF-A expression
and transactivation. We report here that small inhibitory RNA
(siRNA) knockdown of Nox4 in 786-0 human renal tumor cells
expressing empty vector (PRC) or wild-type VHL (WT) results
in 50% decrease in intracellular reactive oxygen species as
measured by a fluorescent 2V,7V-dichlorofluorescin diacetate
assay, and >85% reduction in HIF2-A mRNA and protein levels
by quantitative reverse transcription-PCR and Western blot
analysis. Furthermore, expression of the HIF target genes,
vascular endothelial growth factor, transforming growth
factor-A, and Glut-1 was abrogated by 93%, 74%, and 99%,
respectively, after stable transfection with Nox4 siRNA relative
to nontargeting siRNA, as determined by quantitative reverse
transcription-PCR. Thus, renal Nox4 expression is essential for
full HIF2-A expression and activity in 786-0 renal tumor cells,
even in the absence of functional VHL. We propose the use of
Nox4 as a target in the treatment of clear cell RCC. (Cancer Res
2005; 65(20): 9190-3)
Introduction
Advanced renal cell carcinoma (RCC) is responsible for >12,000
deaths per year in the U.S. Although tumors localized to the kidney
can potentially be cured by surgical resection, one third of patients
present with metastases at the time of diagnosis and half of the
remaining patients will ultimately relapse. Unfortunately, these
tumors are both radio- and chemoresistant, and standard
immunotherapies show complete response in <15% of patients
(1). Thus, new molecularly targeted therapies are desperately
needed for RCC. Greater than 60% of clear cell RCCs harbor
biallelic loss of the von Hippel-Lindau (VHL) tumor suppressor
gene (2). VHL is the substrate-recognition subunit of an SCF-like E3
ubiquitin ligase complex that targets two a-subunits of the
heterodimer transcription factor, hypoxia-inducible factor (HIF)
for degradation (3). HIF regulates hypoxic expression of a number
of genes involved in erythropoiesis, angiogenesis, and anaerobic
metabolism, including erythropoietin, vascular endothelial growth
factor (VEGF), glucose transporter 1 (Glut-1) and transforming
growth factor-a (TGF-a). Under conditions of normal oxygen
tension, HIF-a subunits are rapidly degraded by VHL, and loss of
VHL results in HIF-a stabilization and increased expression of HIF
target genes. Inhibition of HIF2-a was sufficient to suppress VHL-
deficient renal tumor growth (4). Although VHL is widely expressed
(5) and hypoxic HIF activation is a ubiquitous process, familial VHL
patients, who carry a germ line ‘‘first hit’’ VHL mutation, show
marked tissue specificity for malignant transformation. There is a
rapidly growing body of evidence to support a role for redox
signaling by reactive oxygen species (ROS) in HIF transcription
regulation (6). A novel NAD(P)H oxidase highly expressed in renal
tubules, Nox4, has been implicated in oxygen sensing for regulation
of erythropoietin, a HIF-regulated hormone produced solely by the
kidney in adult humans (7, 8). To determine if Nox4 contributes to
the tumorigenic phenotype of VHL loss in the kidney, we examined
HIF-a expression and transcriptional activity in human renal cell
lines after Nox4 knockdown by small inhibitory RNA (siRNA). Here
we present the first report that Nox4 is essential for the full
expression and transcriptional activity of HIF2-a.
Materials and Methods
Cell culture. HeLa, human epithelial kidney (HEK-293), and 786-0, were
maintained in DMEM supplemented with 10% fetal bovine serum,
glutamine, penicillin and streptomycin. 786-0 is a sporadic human RCC
cell line with loss of one VHL allele and truncation of the second at amino
acid 104. The sublines 786-0 (WT) and 786-0 (PRC) were created by stable
transfection of wild-type VHL or empty vector, respectively, and were a gift
from W. Kaelin. Transient transfections of HeLa and HEK-293 were done
using a 3:1 ratio of Fugene6 (Roche Molecular Biochemicals, Branchburg,
NJ) as previously described (9). For luciferase assays, cells were cotrans-
fected with 1 Ag VEGF reporter plasmid DNA (described previously; ref. 9)
and 0.5 Ag Nox4 siRNA, scramble siRNA or buffer and analyzed at 48 hours.
Nucleofection (Amaxa, Cologne, Germany) was used for transfection of
siRNA and vector into 786-0. Briefly, 2 million cells were suspended in 100
AL reagent VCA-1103 (Amaxa) with 0.5 Ag of vector or siRNA duplex and
subjected to nucleofection program G-16. Untransfected controls were
treated identically using an equal volume of buffer in place of vector or
siRNA. Cells were plated onto six-well plates and harvested at 24 hours. For
stable expression, selection with 1 Ag/mL puromycin (Sigma-Aldrich, St.
Louis, MO) was started at 48 hours and clones were screened after 3 weeks.
Inhibition of Nox4 by RNA interference. For the anti-Nox4 RNA
interference experiments, we designed a siRNA specific to human Nox4,
5V-GAGAACAGACCUGACUAUG-3Vfrom nucleotide 1,695 to 1,713 and its com-
plementary sequence. For the nonspecific siRNA (scramble), we employed the
commercially available nontargeting siRNA: 5V-UAGCGACUAAACACAU-
CAAUU-3Vand its complement (Dharmacon, Lafayette, CO). For stable Nox4
knockdown, the siRNA was cloned into a pSilencer 4.1-CMV puro (Ambion,
Austin, TX) as a 54-nucleotide hairpin loop, between restriction sites BamHI
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and HindIII using the oligos: sense, 5V-GATCCGAGAACAGACCTGACTATGTT-
CAAGAGACATAGTCAGGTCTGTTCTCTTA 3V, and antisense 5V-AGCTTA-
AGAGAACAGACCTGACTATGTCTCTTGAACATAGTCAGGTCTGTTCTCG-3V.
Insert sequence was confirmed by DNA sequencing analysis.
Protein extraction and Western blot analysis. An affinity-purified
rabbit anti-human Nox4 antibody was raised against the 139 CVELNAAR-
YRDEDPRKL154 and 564NSYGTRFEYNKESFS578 peptides synthesized and
purified by Biosource (Hopkinton, MA). Adherent cells were washed once
with PBS then lysed in 250 AL of 100 mmol/L NaCl, 20 mmol/L Tris-HCL
(pH 7.6), Igepal CA630 (Sigma), 5 Amol/L MgCl2, 1 mmol/L sodium
orthovanadate, aprotinin (1 Ag/mL), ‘‘complete’’ protease inhibitor (Roche
Applied Science, Indianapolis, IN) and 1 mmol/L 4-(2-aminoethyl)-
bezenesulfonylfluoride-HCl. Protein concentration was determined by the DC
protein assay system (Bio-Rad, Hercules, CA), using bovine serum
albumin (Pierce, Rockford, IL) as a standard. Aliquots (20 Ag) of total
protein were resolved by SDS-PAGE and transferred to polyvinylidene
difluoride (Immobilon-P; Millipore, Bedford, MA) on a semidry transfer
apparatus (Bio-Rad). The Western blots were then incubated with the rabbit
anti-Nox4 antibody or a mouse anti-HIF2-a (Abcam, Cambridge, MA).
Antigen-antibody complexes were detected using the appropriate secondary
antibody linked to horseradish peroxidase and visualized using the Western
Lightening Chemiluminescent Reagent Plus (Perkin-Elmer, Wellesley, MA).
Gene expression assays. In HeLa and HEK-293 cells, luciferase assays
were done using the Steady-Glo luciferase assay system (Promega, Madison,
WI) according to the manufacturer’s instructions. Total RNA was extracted
from cells using RNeasy (Qiagen, Valencia, CA), and quantitative reverse
transcription-PCR was done as described (10). Primers for Nox4, HIF2-a,
VHL, TGF-a, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
are as follows. Nox4 sense 5V-ACAGGGGTCTGCATGGTGGT-3Vand Nox4
antisense, 5V-GCAGCCCTCCTGAAACATGC-3V. HIF2-a sense 5V-TGGCCGC-
TCAGCCTATGAAT-3V and HIF2-a antisense 5V-TGGGTCTCCAGCCA-
CACGTA-3V. VHL sense 5V-GTCACCTTTGGCTCTTCAGAGATGC-3V and
VHL antisense 5V-CTGGCAGTGTGATATTGGCAAAAATAG-3V. TGF-a sense
5V-CAGGTCCGAAAACACTGTGA-3V and TGF-a antisense 5V-GTGTTT-
CTGAGTGGCAGCAA-3V. GAPDH sense 5V-GAAGGTGAAGGTCGGAGTCA-3V
and GAPDH antisense 5V-GACAAGCTTCCCGTTCTCAG-3. Primers for VEGF
and Glut-1 were described previously (9). Reactions were done in triplicate,
normalized to GAPDH value. SE of the mean and t tests were calculated
using SigmaStat 3.1 (Systat Software, Inc., Point Richmond, CA).
Reactive oxygen species production assay. Intracellular generation of
ROS was measured using 2V,7V-dichlorofluorescin diacetate (Sigma-Aldrich)
as described (11). Fluorescence at 530 nm was measured using a Wallac
Victor2 1420 multilabel counter (Wallac Oy, Turku, Finland).
Results
Nox4 knockdown resulted in decreased transcription of
vascular endothelial growth factor and transforming growth
factor-A. To determine if superoxide generation by Nox4 impacted
stabilization or function of HIF-a, we knocked down Nox4 using
specific siRNA. A series of candidate siRNA were transfected into
HEK-293 cells, andNox4 protein was evaluated byWestern blot using
a rabbit antibody raised against Nox4 (Fig. 1A). siRNA2 (lane 4)
consistently showed a 75% to 85% decrease in Nox4 protein
expression and was selected for use in all subsequent experiments.
We next examined the effect of Nox4 knockdown on expression
of VEGF, a gene known to be transcriptionally induced by HIF.
HEK-293 and HeLa cells were transiently cotransfected with a
luciferase reporter containing the minimal promoter and hypoxia
recognition element of VEGF, and either Nox4 siRNA or a nontar-
geting (scramble) siRNA (Fig. 1B). A >70% decrease in transcription
from the VEGF luciferase reporter was seen for Nox4 siRNA relative
to scramble in both cell lines, suggesting that Nox4 activity is
necessary in these cells for full transcriptional regulation of VEGF
under conditions of normal oxygen tension.
To evaluate the impact of Nox4 on endogenous transcription of
HIF-regulated genes, we used quantitative RT-PCR to determine
relative expression levels of Nox4, VEGF, and TGF-a (Fig. 1C). Nox4
siRNA or scramble were transiently transfected into 786-0 human
renal tumor cells with stable expression of wild-type VHL, and total
RNA was harvested after 24 hours. The first three lanes of Fig. 1C
show a 72% reduction of Nox4 mRNA after siRNA transfection
(P = 0.01 when compared with scramble), consistent with the
observed reduction in Nox4 protein expression. Furthermore,
expression of VEGF and TGF-a, known targets of HIF transcription
regulation, decreased by 82% (P = 0.001 relative to scramble) and
72% (P = 0.007 relative to scramble), respectively, suggesting that
Nox4 expression is required for transcription of HIF-regulated
genes at normal oxygen tension, in the presence of intact VHL.
Nox4 knockdown had no impact on expression of the housekeep-
ing gene, GAPDH , used as an internal control.
Figure 1. Transient siRNA knockdown of Nox4. A, Western blot of whole cell
lysates from transiently transfected HEK-293 cells with an array of siRNA
candidates showed greatest protein knockdown for siRNA2 relative to
untransfected (UT) or nontargeting siRNA (scramble). B, luciferase assays
following cotransfection of siRNA2 (siRNA) and VEGF-luciferase reporter in
HEK-293 and HeLa cells show dramatic reduction in transcription from the
reporter plasmid. C, quantitative RT-PCR for Nox4 and the HIF transcription
targets, VEGF, and TGF-a, in 786-0 WT cells transiently transfected with
siRNA or scramble. Columns, mean; bars, F SE; *, P < 0.01.
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Nox4 knockdown resulted in decreased intracellular reac-
tive oxygen species. To evaluate the impact of Nox4 expression on
the HIF pathway in VHL-deficient clear cell RCC, we next estab-
lished stable Nox4 knockdown in the paired 786-0 renal carcinoma
cell lines containing wild-type VHL (WT) or empty vector (PRC).
The Nox4 siRNA or scramble was cloned as a hairpin loop into the
pSilencer 4.1-CMV puro DNA expression vector, and stable trans-
fectants were selected using puromycin. Single cell clones were
screened for reduced production of ROS using a fluorescent 2V,7V-
dichlorofluorescin diacetate assay. Figure 2 shows three candidate
786-0 PRC clones with 50% to 70% reduction in ROS, demonstrating
that loss of Nox4 activity has a significant impact on the oxidative
cellular environment. ROS levels correlated with Nox4 protein
expression as determined by Western blot analysis (data not shown).
Nox4 activity is critical for HIF-regulated gene expression in
the absence of the von Hippel-Lindau tumor suppressor gene.
Stable 786-0 PRC and WT Nox4 knockdown clones demonstrating
the lowest level of intracellular ROS production were selected for
evaluation of HIF-regulated gene expression by quantitative
RT-PCR (Fig. 3). Nox4 knockdown in 786-0 WT again resulted in
dramatic reductions in mRNA expression of VEGF (94%, P <
0.0001) and TGF-a (96%, P < 0.0001), as well as Glut-1 (65%, P =
0.0018), another HIF-regulated gene (Fig. 3B). Of even greater
importance, however, was the finding that increased HIF-regulated
gene expression associated with loss of VHL was also dependent
upon Nox4 activity. In the VHL-deficient 786-0 PRC clones
(Fig. 3A), VEGF, TGF-a, and Glut-1 showed reduced expression
relative to scramble of 93% (P = 0.0001), 74% (P < 0.0001), and 99%
(P < 0.0001), respectively. No significant change was seen in the
expression of Lamin, a non–HIF-regulated gene, following Nox4
knockdown in either cell line. These findings indicate that Nox4
activity is necessary for activation of the HIF pathway even when
HIF-a has accumulated due to loss of the VHL tumor suppressor
and suggest a potential role for Nox4 as a therapeutic target in
clear cell renal carcinoma.
Nox4 knockdown results in decreased transcription of
HIF2-A. To determine at what level Nox4 impacts HIF activity,
we examined HIF2-a mRNA levels by quantitative RT-PCR (Fig. 3)
and were surprised to find that HIF2-a itself was transcriptionally
regulated by Nox4 activity. HIF2-a expression was decreased by
89% (P < 0.0001) and 88% (P = 0.0001) in 786-0 PRC and WT,
respectively. Consistent with prior reports, we found no detectable
expression of HIF1-a in the 786-0 cells. Western blot confirmed
significantly decreased protein expression of HIF2-a in the Nox4
stable knockdown clones relative to stable scramble clones (Fig. 4).
Nox4 knockdown results in decreased transcription of VHL.
Because VHL has been implicated in negative transcriptional
regulation of HIF2-a (12), we also examined VHL mRNA levels by
quantitative PCR in the 786-0 WT stable Nox4 knockdown clone
relative to scramble (Fig. 3B). VHL showed 94% (P = 0.0005)
reduction in expression, suggesting the existence of an oxidative
regulatory circuit whereby VHL and HIF2-a are both positively
regulated by ROS, but HIF2-a activity is attenuated by VHL at both
the transcriptional and posttranslational levels.
Discussion
This represents the first report that Nox4 expression directly
influences HIF2-a expression and activity. We show a dramatic
abrogation of HIF activity even in the absence of functional VHL,
suggesting a role for Nox4 as a target for treatment of clear cell
renal carcinoma.
Despite early contradictory results, there is a rapidly growing
and compelling body of evidence supporting a role for oxidative
signaling in both hypoxic and normoxic regulation of the HIF
pathway, which is well-summarized in a recent review (6). Much of
this work has been done in vascular smooth muscle cells, where
ROS have been implicated in HIF-mediated angiogenesis and
vascular remodeling due to injury.
Nox4, first described as a kidney-specific NADP(H) oxidase, is
most abundant in the kidney (7, 8) where it constitutively produces
Figure 2. Production of intracellular ROS by stable 786-0 PRC Nox4
knockdown clones as measured by the 2V,7V-dichlorofluorescin diacetate
florescent assay. UT, untransfected; scramble, stable expression of nontargeting
siRNA vector. Columns, mean; bars, F SE are indiscernible.
Figure 3. Quantitative RT-PCR in Nox4 siRNA stable 786-0 clones. A, 786-0
PRC, lacking functional VHL product; B, 786-0 WT VHL-expressing cells show
decreased relative expression of HIF2-a and HIF transcription targets VEGF,
Glut-1, and TGF-a and VHL with no significant change in Lamin expression.
Columns, mean; bars, F SE; *, P < 0.005.
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intracellular superoxide in the distal renal tubules adjacent to the
region of erythropoietin production. It is now known to be widely
expressed at lower levels in vascular endothelium, heart, pancreas,
ovary, testis, osteoclasts, placenta, and astrocytes (13) in a pattern
reminiscent of the organ distribution of the clinical manifes-
tations of VHL familial syndrome (14). Nox4 activity elevates
intracellular ROS via rapid conversion of superoxide to other ROS
including hydrogen peroxide, hydroxyl radicals, peroxynitrite,
hypochlorous acid, and singlet oxygen. Superoxide dismutase
(SOD), glutathione peroxidases, catalase, peroxiredoxins, and
thioredoxin function as endogenous antioxidants to maintain
physiologic equilibrium (6). Interestingly, although the kidney of
an affected familial VHL patient shows hundreds of unicellular
sites of HIF-a stabilization consistent with loss of the second
VHL allele, the only multicellular sites are found in the distal
renal tubule where Nox4 expression is located in the human
kidney (15).
In contrast to the HIF1-a knock-out, which results in embryonic
lethality, HIF2-a double knock-out mice are viable but show
multiple-organ pathology, biochemical abnormalities, and altered
gene expression patterns (16). Specifically, they show enhanced
generation of ROS and reduced expression of genes encoding the
primary antioxidant enzymes due to loss of HIF2-a regulation of
antioxidant promoters. Indeed, many aspects of the HIF2-a null
phenotype are reversed by administration of a SOD mimetic,
leading to the proposal of a rheostat role for HIF2-a in the
maintenance of intracellular ROS (16).
A number of studies support a role for Nox4 superoxide
production in the regulation of HIF. Extracellular SOD, the primary
superoxide scavenger, has greatest expression in the kidney, where
it colocalizes with erythropoietin. Homozygous knock-outs show
that SOD functions as a major repressor of erythropoietin
expression (17), consistent with an essential role for superoxide
in HIF transcriptional activity. Homozygous knock-out of JunD also
results in increased intracellular ROS, decreased PDH2 activity,
accumulation of HIF-a and increased VEGF mRNA. Gene
expression profiling revealed a 3-fold up-regulation of Nox4
expression in JunD/ cells versus wild-type (18), suggesting that
JunD might affect HIF-a via increased expression of Nox4.
Furthermore, siRNA knock-down of Rac1, an essential subunit of
the functional NADP(H) complex, results in decreased expression
of HIF1-a and VEGF (19). Finally, Goyal et al. showed that
exogenous expression of the related Nox1 NADP(H) oxidase in
human lung adenocarcinoma cells resulted in accumulation and
transactivation of HIF1-a that could be reversed by the flavopro-
tein inhibitor diphenylene iodonium or catalase (11), again
supporting a role for superoxide production in HIF regulation.
We conclude that Nox4 is directly responsible for HIF2-a
expression and activity and is critical to HIF2-a activity even in
VHL-deficient RCC. As the predominant renal NADP(H) oxidase,
Nox4 has a number of qualities that make it a promising target for
manipulation of HIF activity in RCC, including relative tissue
specificity and cell membrane localization. Investigational drugs
aimed at individual downstream components of the VHL-HIF
pathway have shown clinical activity in advanced RCC (20). We
propose that specific inhibition of Nox4 may prove more effective
by down-regulating the entire array of HIF-dependent genes that
are overexpressed in RCC.
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Figure 4. Western blot demonstrating decreased protein levels of HIF2-a in the
human renal cancer cell line 786-0 containing empty vector (PRC) or wild-type
VHL (WT) after stable expression of Nox4 siRNA versus scramble.
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